MACROD2 gene may explain why some breast cancers are resistant to tamoxifen

[News]

After mining the genetic records of thousands of breast cancer patients, researchers from the Johns Hopkins Kimmel Cancer Center have identified a gene whose presence may explain why some breast cancers are resistant to tamoxifen, a widely used hormone treatment generally used after surgery, radiation and other chemotherapy.

More... (http://www.news-medical.net/news/20141125/MACROD2-gene-may-explain-why-some-breast-cancers-are-resistant-to-tamoxifen.aspx)